check / the evidence

Go to the record behind the claim.

Use the source that answers the question you have. Licence details, product labels and payment rules each answer a different question.

For the clinician or pharmacy: check the licence.

The Federation of State Medical Boards directory links to state boards for doctors with MD or DO after their names.a

Those boards hold doctor licence records and records of penalties they have imposed; a clear record does not rate the doctor's care.b

FDA links to state pharmacy licence searches.c

Use the exact name you were given. Match the state and read the record's own explanation of its status.

For the medicine: ask for the product record.

As of September 2026, entering a maker in FDA's records or giving a medicine a directory code does not show that the medicine is approved.dh

Compounded preparations have no FDA approval as of September 2026; their safety, quality and effect receive no FDA review before supply.e

Ask the clinician to point to the exact product information and explain what it says about the proposed use.

For rules and prices: read the date and limits.

Keep the date with a quote about payment or product status. Ask whether the answer applies to your product and circumstances.

FDA publishes a searchable collection of warning letters.f

A warning letter states what FDA believed was wrong when it wrote to a company; it is not a final decision.

FDA and the company may exchange more information later, changing whether FDA considers the company to be following the rules.f

Read the date and look for a later company reply or a follow-up from FDA before judging what the letter means today.

Medicare's GLP-1 Bridge operates temporarily with eligibility rules as of September 2026; ordinary Part D cover is unchanged.g

GLP-1 medicines act like a hormone, a chemical messenger in the body, involved in appetite and blood sugar.

Bring unclear parts back to the clinician or your plan.